BioStem Technologies, Inc. (BSEM)

3.53 -0.32 (-8.31%) USD  |  NASDAQ  |  Aug 28, 16:00
3.50 -0.03 (-0.85%) After-Hours: 20:00
More

BioStem Technologies Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for BSEM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
August 24, 2026 --
May 15, 2026 --
May 06, 2026 --
August 15, 2025 --
May 13, 2025 --
April 15, 2025 --
February 24, 2025 --
December 31, 2024 --
Date Value
November 15, 2024 --
November 13, 2024 --
October 17, 2024 --
October 02, 2024 --
August 13, 2024 --
May 15, 2024 --
April 02, 2024 --
February 01, 2024 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Filana Therapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
Eloxx Pharmaceuticals, Inc. Upgrade
Cannabis Global, Inc. --
Breakthrough Chemistry, Inc. --

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade